Bianca Tesi

Bianca Tesi

Auto-generated profile, based on publicly available information

Bianca Tesi

Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Immunity
Verified
Journal Article
Closed access
HSHeinrich Schlums
Heinrich Schlums
FCFrank Cichocki
Frank Cichocki
BTBianca Tesi
Bianca Tesi
JTJakob Theorell
Jakob Theorell
Vivien BéziatVivien Béziat
Vivien Béziat
YBYenan T. Bryceson
Yenan T. Bryceson

20 April 2017 in Blood
Verified
Journal Article
Open access
PDF file
BTBianca Tesi
Bianca Tesi
JDJosef Davidsson
Josef Davidsson
MVMatthias Voss
Matthias Voss
ERElisa J Rahikkala
Elisa J Rahikkala
THTim D. Holmes
Tim D. Holmes
YBYenan T. Bryceson
Yenan T. Bryceson
Key Points: Autosomal-dominant SAMD9L gain-of-function mutations predispose to myeloid malignancies involving chromosome 7 aberrations. Hematopoietic reversions frequently occur postnatally and are associated with milder disease manifestations.

28 May 2015 in Haematologica
Verified
Journal Article
Open access
PDF file
SBS. F. Bode
S. F. Bode
SAS. Ammann
S. Ammann
WAW. Al-Herz
W. Al-Herz
MBM. Bataneant
M. Bataneant
CDC. C. Dvorak
C. C. Dvorak
FEFor The Inborn Errors Working Party Of The Ebmt
For The Inborn Errors Working Party Of The Ebmt
Hemophagocytic lymphohistiocytosis is a hyperinflammatory syndrome defined by clinical and laboratory criteria. Current criteria were created to identify patients with familial hemophagocytic lmyphohistiocytosis in immediate need of immunosuppressive therapy. However, these criteria also identify patients with infection-associated hemophagocytic inflammatory states lacking genetic defects typically predisposing to hemophagocytic lymphohistiocytosis. These patients include those with primary immunodeficiencies, in whom the pathogenesis of the inflammatory syndrome may be distinctive and aggressive immunosuppression is contraindicated. To better characterize hemophagocytic inflammation associated with immunodeficiencies, we combined an international survey with a literature search and identified 63 patients with primary immunodeficiencies other than cytotoxicity defects or X-linked lymphoproliferative disorders, presenting with conditions fulfilling current criteria for hemophagocytic lymphohistiocytosis. Twelve patients had severe combined immunodeficiency with <100/μL T cells, 18 had partial T-cell deficiencies; episodes of hemophagocytic lymphohistiocytosis were mostly associated with viral infections. Twenty-two patients had chronic granulomatous disease with hemophagocytic episodes mainly associated with bacterial infections. Compared to patients with cytotoxicity defects, patients with T-cell deficiencies had lower levels of soluble CD25 and higher ferritin concentrations. Other criteria for hemophagocytoc lymphohistiocytosis were not discriminative. Thus: (i) a hemophagocytic inflammatory syndrome fulfilling criteria for hemophagocytic lymphohistiocytosis can be the initial manifestation of primary immunodeficiencies; (ii) this syndrome can develop despite severe deficiency of T and NK cells, implying that the pathophysiology is distinct and not appropriately described as “lympho”-histiocytosis in these patients; and (iii) current criteria for hemophagocytoc lymphohistiocytosis are insufficient to differentiate hemophagocytic inflammatory syndromes with different pathogeneses. This is important because of implications for therapy, in particular for protocols targeting T cells.

30 July 2018 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
FCFrank Cichocki
Frank Cichocki
CWCheng-Ying Wu
Cheng-Ying Wu
BZBin Zhang
Bin Zhang
MFMartin Felices
Martin Felices
BTBianca Tesi
Bianca Tesi
JMJeffrey Miller
Jeffrey Miller
Natural killer (NK) cells with adaptive immunological properties expand and persist in response to human cytomegalovirus. Here, we explored the metabolic processes unique to these cells. Adaptive CD3−CD56dimCD57+NKG2C+ NK cells exhibited metabolic hallmarks of lymphocyte memory, including increased oxidative mitochondrial respiration, mitochondrial membrane potential, and spare respiratory capacity. Mechanistically, we found that a short isoform of the chromatin-modifying transcriptional regulator, AT-rich interaction domain 5B (ARID5B), was selectively induced through DNA hypomethylation in adaptive NK cells. Knockdown and overexpression studies demonstrated that ARID5B played a direct role in promoting mitochondrial membrane potential, expression of genes encoding electron transport chain components, oxidative metabolism, survival, and IFN-γ production. Collectively, our data demonstrate that ARID5B is a key regulator of metabolism in human adaptive NK cells, which, if targeted, may be of therapeutic value. Graphical Abstract

9 January 2017 in Nature Medicine
Verified
Journal Article
Closed access
Nikolas HeroldNikolas Herold
Nikolas Herold
SRSean Rudd
Sean Rudd
LLLinda Ljungblad
Linda Ljungblad
KSKumar Sanjiv
Kumar Sanjiv
IMIda Hed Myrberg
Ida Hed Myrberg
TSTorsten Schaller
Torsten Schaller

1 June 2015 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Open access
BTBianca Tesi
Bianca Tesi
ESElena Sieni
Elena Sieni
CNConceição Neves
Conceição Neves
FRFrancesca Romano
Francesca Romano
VCValentina Cetica
Valentina Cetica
YBYenan T. Bryceson
Yenan T. Bryceson